OPCH
Option Care Health, Inc. NASDAQ Listed Aug 15, 1996$21.96
After hrs
$21.99
+0.00%
Mkt Cap $3.4B
52w Low $18.01
21.0% of range
52w High $36.80
50d MA $23.19
200d MA $28.61
P/E (TTM)
17.0x
EV/EBITDA
6.8x
P/B
2.6x
Debt/Equity
0.0x
ROE
15.7%
P/FCF
13.6x
RSI (14)
51.20
ATR (14)
$0.66
Beta
0.95
50d MA
$23.19
200d MA
$28.61
Avg Volume
3.6M
Option Care Health, Inc. offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including Crohn's disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders. It also offers treatments to manage the progression of neurological disorders, such as amyotrophic lateral sclerosis and duchenne muscular dystrophy; infusion therapies for bleeding disorders; therapies that women need to survive and thrive through high-risk pregnancies; and other infusion therapies to treat various conditions, including pain management, chemotherapy, and respiratory medications, as well as nursing services. Option Care Health, Inc. is headquartered in Bannockburn, Illinois.
3000 Lakeside Drive · Bannockburn, IL 60015 · US
| Date | Time | Est | Rptd | Surp | Base | Gap% | D1% | D2% | D3% | D4% | D5% | Guide ▲★ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Apr 30, 2026 | BMO | 0.37 | 0.40 | +8.1% | 26.87 | -26.4% | -24.3% | -1.5% | +5.5% | +0.8% | -4.0% | — |
| Feb 24, 2026 | BMO | 0.46 | 0.46 | +0.0% | 36.09 | -7.1% | -6.3% | -0.7% | -5.1% | +1.8% | -2.6% | — |
| Oct 30, 2025 | BMO | 0.43 | 0.45 | +4.7% | 28.67 | -9.4% | -8.6% | -0.7% | +1.5% | +2.3% | +0.2% | — |
| Jul 30, 2025 | BMO | 0.40 | 0.41 | +2.5% | 30.13 | -2.6% | +1.7% | -4.2% | -3.7% | +0.0% | -0.6% | — |
| Apr 29, 2025 | BMO | 0.36 | 0.40 | +11.1% | 32.97 | +2.7% | -6.9% | +5.3% | -0.4% | +2.4% | -0.4% | — |
| Feb 26, 2025 | BMO | 0.33 | 0.35 | +6.1% | 32.63 | -3.6% | +1.6% | +0.2% | +0.9% | +1.4% | +0.5% | — |
| Oct 30, 2024 | BMO | 0.31 | 0.31 | +0.0% | 30.50 | -19.6% | -22.8% | -2.2% | +4.6% | -6.7% | -0.8% | — |
| Jul 31, 2024 | BMO | 0.27 | 0.30 | +11.1% | 31.35 | +2.5% | -5.3% | +3.6% | +2.7% | -6.1% | +0.3% | — |
| Apr 23, 2024 | BMO | 0.23 | 0.26 | +13.0% | 30.41 | +1.9% | +0.6% | -2.2% | -2.1% | +1.1% | +2.2% | — |
| Feb 22, 2024 | BMO | 0.29 | 0.32 | +10.3% | 33.36 | +1.9% | -2.4% | -1.0% | -3.0% | +4.8% | -3.5% | — |
| Oct 25, 2023 | BMO | 0.28 | 0.31 | +10.7% | 32.87 | -2.6% | -15.5% | -0.2% | -4.0% | +0.8% | +3.4% | — |
| Jul 27, 2023 | BMO | 0.22 | 0.63 | +186.4% | 32.44 | +4.8% | +4.4% | +0.9% | -1.1% | -0.1% | -0.3% | — |
| Date | Firm | Action | Grade | Target | Base | Open | Gap% | D1% | D2% | D3% | D4% | D5% |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Jun 8 | Goldman | Initiates | Neutral | $22 | $20.51 | $20.15 | -1.8% | -2.1% | +5.1% | +1.3% | -2.8% | -0.1% |
| May 1 | UBS | Maintains | Buy → Buy | — | $20.33 | $20.20 | -0.6% | -1.5% | +5.5% | +0.8% | -4.0% | +1.5% |
| May 1 | TD Cowen | Maintains | Hold → Hold | — | $20.33 | $20.20 | -0.6% | -1.5% | +5.5% | +0.8% | -4.0% | +1.5% |
| May 1 | Barrington Research | Maintains | Outperform → Outperform | — | $20.33 | $20.20 | -0.6% | -1.5% | +5.5% | +0.8% | -4.0% | +1.5% |
| Jan 16 | Barrington Research | Maintains | Outperform → Outperform | — | $36.11 | $35.92 | -0.5% | -0.2% | -0.7% | +1.3% | +0.9% | -0.9% |
| Jan 13 | Citizens | Maintains | Market Outperform → Market Outperform | — | $32.06 | $35.25 | +10.0% | +8.4% | +2.2% | +1.7% | -0.2% | -0.7% |
| Jan 13 | Morgan Stanley | Maintains | Overweight → Overweight | — | $32.06 | $35.25 | +10.0% | +8.4% | +2.2% | +1.7% | -0.2% | -0.7% |
| Dec 9 | Deutsche Bank | Maintains | Buy → Buy | — | $30.59 | $30.81 | +0.7% | +5.3% | +2.7% | -0.6% | +1.0% | +0.9% |
| Dec 9 | BofA Securities | Maintains | Buy → Buy | — | $30.59 | $30.81 | +0.7% | +5.3% | +2.7% | -0.6% | +1.0% | +0.9% |
| Nov 3 | TD Cowen | Maintains | Hold → Hold | — | $26.03 | $26.03 | +0.0% | +1.5% | +2.3% | +0.2% | -0.1% | +2.3% |
| Oct 31 | Barrington Research | Maintains | Outperform → Outperform | — | $26.21 | $26.02 | -0.7% | -0.7% | +1.5% | +2.3% | +0.2% | -0.1% |
| Oct 31 | Citizens | Maintains | Market Outperform → Market Outperform | — | $26.21 | $26.02 | -0.7% | -0.7% | +1.5% | +2.3% | +0.2% | -0.1% |
| Sep 23 | Barrington Research | Maintains | Outperform → Outperform | — | $28.67 | $28.74 | +0.2% | -3.4% | -0.7% | -2.5% | +1.8% | +0.9% |
| Jul 31 | JMP Securities | Maintains | Market Outperform → Market Outperform | — | $30.64 | $30.52 | -0.4% | -4.2% | -3.7% | +0.0% | -0.6% | -0.7% |
| Jul 10 | Barrington Research | Maintains | Outperform → Outperform | — | $30.64 | $30.56 | -0.3% | -0.5% | -2.0% | +2.7% | +0.2% | -1.1% |
| Jun 18 | JMP Securities | Maintains | Market Outperform → Market Outperform | — | $31.84 | $31.83 | -0.0% | -0.9% | -0.1% | -1.5% | +3.9% | -1.5% |
| Apr 30 | Barrington Research | Maintains | Outperform → Outperform | — | $30.69 | $31.28 | +1.9% | +5.3% | -0.4% | +2.4% | -0.4% | -0.2% |
| Apr 30 | UBS | Upgrade | Neutral → Buy | — | $30.69 | $31.28 | +1.9% | +5.3% | -0.4% | +2.4% | -0.4% | -0.2% |
| Apr 22 | JMP Securities | Maintains | Market Outperform → Market Outperform | — | $31.25 | $31.43 | +0.6% | +0.9% | +1.8% | +0.2% | +2.2% | +0.2% |
| Apr 21 | Barrington Research | Maintains | Outperform → Outperform | — | $32.02 | $31.88 | -0.4% | -2.4% | +0.9% | +1.8% | +0.2% | +2.2% |
| Mar 6 | JP Morgan | Maintains | Overweight → Overweight | — | $34.60 | $34.38 | -0.6% | -1.0% | -0.7% | -1.9% | +0.1% | -1.6% |
| Feb 27 | Barrington Research | Maintains | Outperform → Outperform | — | $33.15 | $33.33 | +0.5% | +0.2% | +0.9% | +1.4% | +0.5% | +1.4% |
| Jan 24 | JP Morgan | Maintains | Overweight → Overweight | — | $30.00 | $29.81 | -0.6% | +1.1% | +3.6% | -1.9% | +0.4% | +1.5% |
| Jan 23 | Jefferies | Upgrade | Hold → Buy | — | $29.31 | $30.43 | +3.8% | +2.4% | +1.1% | +3.6% | -1.9% | +0.4% |
| Jan 14 | Barrington Research | Maintains | Outperform → Outperform | — | $27.72 | $27.97 | +0.9% | +3.6% | +0.1% | +1.9% | -0.5% | +1.1% |
| Jan 10 | JMP Securities | Maintains | Market Outperform → Market Outperform | — | $24.14 | $23.68 | -1.9% | -0.6% | +15.5% | +3.6% | +0.1% | +1.9% |
| Nov 5 | Goldman Sachs | Downgrade | Buy → Neutral | — | $22.49 | $22.42 | -0.3% | -0.8% | +5.3% | -2.4% | -2.0% | +1.7% |
| Nov 1 | Truist | Maintains | Buy → Buy | — | $23.04 | $23.09 | +0.2% | +4.6% | -6.7% | -0.8% | +5.3% | -2.4% |
| Oct 31 | Barrington Research | Maintains | Outperform → Outperform | — | $23.55 | $23.41 | -0.6% | -2.2% | +4.6% | -6.7% | -0.8% | +5.3% |
| Oct 31 | Jefferies | Downgrade | Buy → Hold | — | $23.55 | $23.41 | -0.6% | -2.2% | +4.6% | -6.7% | -0.8% | +5.3% |
| Oct 23 | Barrington Research | Maintains | Outperform → Outperform | — | $30.34 | $30.27 | -0.2% | -1.0% | -1.0% | -1.0% | +2.4% | +1.2% |
| Sep 30 | JMP Securities | Maintains | Market Outperform → Market Outperform | — | $31.42 | $31.42 | +0.0% | -0.4% | -3.7% | -0.9% | -2.0% | -0.4% |
| Aug 1 | Barrington Research | Maintains | Outperform → Outperform | — | $29.69 | $29.97 | +0.9% | +3.6% | +2.7% | -6.1% | +0.3% | -1.8% |
| Jul 25 | Barrington Research | Maintains | Outperform → Outperform | — | $30.99 | $31.08 | +0.3% | +0.0% | +0.5% | -0.8% | +1.5% | -5.3% |
| Apr 24 | Barrington Research | Maintains | Outperform → Outperform | — | $30.59 | $30.84 | +0.8% | -2.2% | -2.1% | +1.1% | +2.2% | -1.2% |
| Mar 4 | Jefferies | Maintains | Buy → Buy | — | $32.12 | $32.19 | +0.2% | +2.1% | -0.9% | -0.4% | +1.7% | -1.8% |
| Feb 23 | Barrington Research | Maintains | Outperform → Outperform | — | $32.55 | $32.57 | +0.1% | -1.0% | -3.0% | +4.8% | -3.5% | +2.1% |
| Oct 26 | Barrington Research | Maintains | Outperform → Outperform | — | $27.78 | $28.15 | +1.3% | -0.2% | -4.0% | +0.8% | +3.4% | +3.4% |
| Oct 18 | JP Morgan | Maintains | Overweight → Overweight | — | $33.01 | $32.97 | -0.1% | -2.2% | +0.2% | -0.2% | -0.4% | +2.3% |
| Jul 28 | Barrington Research | Maintains | Outperform → Outperform | — | $33.86 | $34.32 | +1.4% | +0.9% | -1.1% | -0.1% | -0.3% | -0.1% |
| Jun 27 | Truist | Maintains | Buy → Buy | — | $31.87 | $31.63 | -0.8% | -1.4% | -0.4% | +2.0% | +1.8% | -0.2% |
| May 5 | Deutsche Bank | Maintains | Buy → Buy | — | $27.50 | $27.78 | +1.0% | +1.7% | +0.6% | -2.9% | -1.2% | +0.7% |
| May 5 | Barrington Research | Maintains | Outperform → Outperform | — | $27.50 | $27.78 | +1.0% | +1.7% | +0.6% | -2.9% | -1.2% | +0.7% |
| Oct 28 | Barrington Research | Maintains | Outperform → Outperform | — | $30.78 | $30.67 | -0.4% | +1.4% | -3.0% | +0.2% | -1.0% | +1.0% |
| Aug 22 | Goldman Sachs | Maintains | Buy → Buy | — | $32.32 | $32.44 | +0.4% | +0.1% | -0.4% | +1.5% | +0.3% | -3.6% |
| Jul 28 | Barrington Research | Maintains | Outperform → Outperform | — | $33.16 | $33.24 | +0.2% | +2.3% | -1.0% | +0.8% | +3.4% | -0.7% |
| Aug 4 | Canaccord Genuity | Maintains | Buy → Buy | — | $21.29 | $21.00 | -1.4% | -4.5% | +5.2% | +3.1% | -1.6% | -1.1% |
| Jul 19 | Goldman Sachs | Upgrade | Neutral → Buy | — | $19.98 | $20.28 | +1.5% | +0.6% | +3.6% | +2.3% | -0.3% | +0.0% |
| Mar 12 | Canaccord Genuity | Maintains | Buy → Buy | — | $20.72 | $20.90 | +0.9% | -3.4% | +6.5% | -6.4% | -0.6% | -5.0% |
| Jan 22 | Deutsche Bank | Maintains | Buy → Buy | — | $19.33 | $19.50 | +0.9% | +1.3% | +0.3% | -2.1% | -5.6% | +3.5% |
| Date | Insider | Title | Type | Shares | Price | Value | Owned After | D1% | D5% |
|---|---|---|---|---|---|---|---|---|---|
| May 7, 2026 | SULLIVAN TIMOTHY PDir | — | Buy | 24,154 | $20.69 | $500K | 73,383 | -1.16% | +0.86% |
| May 4, 2026 | KRAEMER HARRY M JANSEN JRDir | — | Buy | 36,610 | $21.41 | $784K | 450,000 | -3.99% | -1.21% |
| May 4, 2026 | Sethna MeenalOff | Chief Financial Officer | Buy | 16,225 | $20.16 | $327K | 98,337 | +0.76% | -3.32% |
| May 4, 2026 | RADEMACHER JOHN CHARLESDir/Off | Chief Executive Officer | Buy | 12,500 | $21.18 | $265K | 695,152 | +0.76% | -3.32% |
8-K
Option Care Health, Inc. -- 8-K Filing
May 22
8-K · 7.01
! Medium
Option Care Health, Inc. -- 8-K 7.01: Regulation FD Disclosure
May 12
8-K · 7.01
! Medium
Option Care Health, Inc. -- 8-K 7.01: Regulation FD Disclosure
Option Care Health (OPCH) disclosed supplemental presentation materials to investors via Regulation FD, providing additional context beyond their press release without formal SEC filing implications.
Apr 30
8-K · 1.01
! Medium
Unknown — 8-K 1.01: Financing / Debt Agreement
Bank of America's debt restructuring likely indicates refinancing activity that could improve liquidity terms, potentially benefiting shareholders if rates are favorable or covenant flexibility increases.
Apr 2
8-K
Option Care Health, Inc. -- 8-K Filing
Option Care Health reported fourth quarter and full year 2025 financial results, with the filing signed by CFO Meenal Sethna on February 24, 2026.
Feb 24
Institutional (13F) — Top 20
All ↗
| # | Manager | Shares | Value | Chg | Period |
|---|---|---|---|---|---|
| 1 | Durable Capital Partners Lp | 8,991,254 | $242M | — | Mar 2026 |
| 2 | Morgan Stanley | 6,820,466 | $217M | Added | Dec 2025 |
| 3 | Vanguard Portfolio Management Llc | 8,062,555 | $217M | New | Mar 2026 |
| 4 | Vanguard Capital Management Llc | 7,016,323 | $189M | New | Mar 2026 |
| 5 | Fmr Llc | 6,426,119 | $173M | Reduced | Mar 2026 |
| 6 | Arrowstreet Capital, Limited Partnership | 4,236,237 | $114M | — | Mar 2026 |
| 7 | Citadel Advisors Llc | 3,537,458 | $95M | Added | Mar 2026 |
| 8 | Boston Partners | 2,431,467 | $66M | Added | Mar 2026 |
| 9 | Bank Of America Corp /de/ | 1,945,015 | $52M | Added | Mar 2026 |
| 10 | Northern Trust Corp | 1,945,000 | $52M | Reduced | Mar 2026 |
| 11 | Duquesne Family Office | 1,868,550 | $50M | Added | Mar 2026 |
| 12 | Alyeska Investment Group, L.p. | 1,781,365 | $48M | Added | Mar 2026 |
| 13 | Swedbank Ab | 1,726,000 | $46M | — | Mar 2026 |
| 14 | Millennium Management | 1,640,991 | $44M | Added | Mar 2026 |
| 15 | Nuveen, Llc | 1,620,872 | $44M | Added | Mar 2026 |
| 16 | Van Berkom & Associates Inc. | 1,587,636 | $43M | New | Mar 2026 |
| 17 | Fort Washington Investment Advisors Inc /oh/ | 1,479,728 | $40M | Added | Mar 2026 |
| 18 | Geneva Capital Management Llc | 1,474,121 | $40M | Added | Mar 2026 |
| 19 | Jennison Associates Llc | 1,163,931 | $37M | Reduced | Dec 2025 |
| 20 | Bank Of New York Mellon Corp | 1,083,023 | $29M | Reduced | Mar 2026 |
Mutual Funds / ETFs (N-PORT) — Top 20
All ↗
Valuation
Market Cap
$3.45B
Enterprise Value
$3.24B
P/E (TTM)
16.96x
Forward P/E
11.77x
PEG Ratio
5.98x
P/B
2.62x
P/S
0.62x
P/FCF
13.58x
EV/EBITDA
6.82x
Shares Out
159.8M
Financials (TTM)
Revenue
$5.65B
Net Income
$207.6M
EBITDA
$474.5M
Free Cash Flow
$258.4M
Op Cash Flow
$258.4M
EPS Basic
$1.28
EPS Diluted
$1.28
EPS Forward
$1.87
Gross Margin
19.3%
Op Margin
6.0%
Net Margin
3.7%
Balance Sheet
Total Assets
$3.46B
Total Liab.
$2.13B
Total Equity
$1.33B
Cash
$232.6M
LT Debt
$0
Book Value/Sh
$8.38
Debt/Equity
0.00x
Current Ratio
1.53
Quick Ratio
0.96
Returns & Growth
ROE
15.7%
ROA
6.0%
ROIC
9.4%
Rev Growth YoY
+13.0%
EPS Growth YoY
+4.1%
Price Returns
2W
+4.6%
1M
+2.7%
3M
-35.7%
6M
-32.9%
12M
-36.1%
Technicals
52W High
$36.80
52W Low
$18.01
50d MA
$23.19
200d MA
$28.61
RSI (14)
51.20
ATR (14)
$0.66
Beta
0.95
Avg Volume
3.6M
Dividends
Div Rate
$0.00
Div Yield
—
Frequency
—
Ex-Div Date
—
Analyst Price Targets
Consensus
$38.67
High
$42.00
Low
$36.00
Median
$38.50
Data updated apr 26, 2026 5:38pm
· Source: financialmodelingprep.com